Dr. Buffington on MRI Fusion for Prostate Cancer

Video

Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses MRI fusion-guided biopsy in patients with prostate cancer.

Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses MRI fusion-guided biopsy in patients with prostate cancer.

MRI fusion is done in many groups for the second biopsy for patients with prostate cancer, Buffington explains. A patient receiving MRI fusion is either on active surveillance with known prostate cancer or had a negative biopsy in the past but their prostate-specific antigen (PSA) is still rising.

The MRI is not so much for screening but helps target an area that may have been missed on a prior biopsy. A patient receives an MRI and if there is a concerning area the physicians take those images and fuse it with the images from the ultrasound to better target the area and biopsy it, says Buffington.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine